Walleye Capital LLC
- SEC CIK
- 0001758720
- Latest filing
- Aug 3, 2026
ALDX holding history
Aldeyra Therapeutics, Inc. in every 13F filed by Walleye Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALDX overviewAll 13F holders of ALDXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −18,595−100.0% | Sold out | Holders |
| Q4 2025 | 18,595 | $96.3K | <0.1% | +18,595 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −155,609−100.0% | Sold out | Holders |
| Q2 2025 | 155,609 | $596.0K | <0.1% | +155,609 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −13,706−100.0% | Sold out | Holders |
| Q4 2024 | 13,706 | $68.4K | <0.1% | +13,706 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −14,168−100.0% | Sold out | Holders |
| Q2 2024 | 14,168 | $46.9K | <0.1% | +14,168 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −41,652−100.0% | Sold out | Holders |
| Q1 2022 | 41,652 | $185.0K | <0.1% | −314,209−88.3% | Reduced | Holders |
| Q4 2021 | 355,861 | $1.42M | <0.1% | +355,861 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −179,810−100.0% | Sold out | Holders |
| Q2 2021 | 179,810 | $2.04M | 0.1% | +179,810 | New | Holders |